Fragile X-like behaviors and abnormal cortical dendritic spines in Cytoplasmic FMR1-interacting protein 2-mutant mice

Human Molecular Genetics

Volumn 24, Issue 7, 2014, Pages 1813-1823

  Han, Kihoon ^a,b   Chen, Hogmei ^a,b   Gennarino, Vincenzo A ^a   Richman, Ronald ^a,b   Lu, Hui Chen ^a,b   Zoghbi, Huda Y ^a,b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; METABOTROPIC RECEPTOR; RNA BINDING PROTEIN; CYFIP2 PROTEIN, MOUSE; NERVE PROTEIN;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN CELL; CONTROLLED STUDY; CYTOPLASMIC FMR1 INTERACTING PROTEIN 2 GENE; DENDRITIC SPINE; FEMALE; FMR1 GENE; FRAGILE X SYNDROME; GENE; GENE EXPRESSION REGULATION; GENE LOSS; GENE SILENCING; HIPPOCAMPUS; INTELLECTUAL IMPAIRMENT; MALE; MOUSE; MUTANT MOUSE STRAIN; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ABNORMALITIES; ANIMAL; ANIMAL BEHAVIOR; BRAIN CORTEX; C57BL MOUSE; CYTOPLASM; DEFICIENCY; DISEASE MODEL; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALIA; MUS;

ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; CYTOPLASM; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS;

EID: 84926453554     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu595     Document Type: Article

References (47)

1. Bhakar, A.L., Dolen, G. and Bear, M.F. (2012) The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci., 35, 417-443.
2. Santoro, M.R., Bray, S.M. and Warren, S.T. (2012) Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu. Rev. Pathol., 7, 219-245.
3. Pieretti, M., Zhang, F.P., Fu, Y.H., Warren, S.T., Oostra, B.A., Caskey, C.T. and Nelson, D.L. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell, 66, 817-822.
4. Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F.P. et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914.
5. Heitz, D., Rousseau, F., Devys, D., Saccone, S., Abderrahim, H., Le Paslier, D., Cohen, D., Vincent, A., Toniolo, D., Della Valle, G. et al. (1991) Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island. Science, 251, 1236-1239.
6. Fu, Y.H., Kuhl, D.P., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J., Holden, J.J., Fenwick, R.G. Jr., Warren, S.T. et al. (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell, 67, 1047-1058.
7. Darnell, J.C. and Klann, E. (2013) The translation of translational control by FMRP: therapeutic targets for FXS. Nat. Neurosci., 16, 1530-1536.
8. Huber, K.M., Gallagher, S.M.,Warren, S.T. and Bear, M.F. (2002) Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl Acad. Sci. USA, 99, 7746-7750.
9. Nosyreva, E.D. and Huber, K.M. (2006) Metabotropic receptordependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. J. Neurophysiol., 95, 3291-3295.
10. Krueger, D.D. and Bear, M.F. (2011) Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu. Rev. Med., 62, 411-429.
11. Comery, T.A., Harris, J.B., Willems, P.J., Oostra, B.A., Irwin, S.A., Weiler, I.J. and Greenough, W.T. (1997) Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl Acad. Sci. USA, 94, 5401-5404.
12. Irwin, S.A., Patel, B., Idupulapati, M., Harris, J.B., Crisostomo, R.A., Larsen, B.P., Kooy, F., Willems, P.J., Cras, P., Kozlowski, P.B. et al. (2001) Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am. J. Med. Genet., 98, 161-167.
13. Hering, H. and Sheng, M. (2001) Dendritic spines: structure, dynamics and regulation. Nat. Rev. Neurosci., 2, 880-888.
14. Nakayama, A.Y., Harms, M.B. and Luo, L. (2000) Small GTPases Rac and Rho in the maintenance of dendritic spines and branches in hippocampal pyramidal neurons. J. Neurosci., 20, 5329-5338.
15. Castets, M., Schaeffer, C., Bechara, E., Schenck, A., Khandjian, E.W., Luche, S., Moine, H., Rabilloud, T., Mandel, J.L. and Bardoni, B. (2005) FMRP interferes with the Rac1 pathway and controls actin cytoskeleton dynamics in murine fibroblasts. Hum. Mol. Genet., 14, 835-844.
16. Chen, L.Y., Rex, C.S., Babayan, A.H., Kramar, E.A., Lynch, G., Gall, C.M. and Lauterborn, J.C. (2010) Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome. J. Neurosci., 30, 10977-10984.
17. Schenck, A., Bardoni, B., Langmann, C., Harden, N., Mandel, J.L. and Giangrande, A. (2003) CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron, 38, 887-898.
18. Hayashi, M.L., Rao, B.S., Seo, J.S., Choi, H.S., Dolan, B.M., Choi, S.Y., Chattarji, S. and Tonegawa, S. (2007) Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc. Natl Acad. Sci. USA, 104, 11489-11494.
19. Dolan, B.M., Duron, S.G., Campbell, D.A., Vollrath, B., Shankaranarayana Rao, B.S., Ko, H.Y., Lin, G.G., Govindarajan, A., Choi, S.Y. and Tonegawa, S. (2013) Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proc. Natl Acad. Sci. USA, 110, 5671-5676.
20. Schenck, A., Bardoni, B., Moro, A., Bagni, C. and Mandel, J.L. (2001) A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc. Natl Acad. Sci. USA, 98, 8844-8849.
21. Takenawa, T. and Suetsugu, S. (2007) The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat. Rev. Mol. Cell Biol., 8, 37-48.
22. Chen, Z., Borek, D., Padrick, S.B., Gomez, T.S., Metlagel, Z., Ismail, A.M., Umetani, J., Billadeau, D.D., Otwinowski, Z. and Rosen, M.K. (2010) Structure and control of the actin regulatory WAVE complex. Nature, 468, 533-538.
23. Kunda, P., Craig, G., Dominguez, V. and Baum, B. (2003) Abi, Sra1, and Kette control the stability and localization of SCAR/WAVE to regulate the formation of actin-based protrusions. Curr. Biol., 13, 1867-1875.
24. Zhao, L., Wang, D., Wang, Q., Rodal, A.A. and Zhang, Y.Q. (2013) Drosophila cyfip regulates synaptic development and endocytosis by suppressing filamentous actin assembly. PLoS Genet., 9, e1003450.
25. Abekhoukh, S. and Bardoni, B. (2014) CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome. Front. Cell. Neurosci., 8, 81.
26. Napoli, I., Mercaldo, V., Boyl, P.P., Eleuteri, B., Zalfa, F., De Rubeis, S., Di Marino, D., Mohr, E., Massimi, M., Falconi, M. et al. (2008) The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell, 134, 1042-1054.
27. Bozdagi, O., Sakurai, T., Dorr, N., Pilorge, M., Takahashi, N. and Buxbaum, J.D. (2012) Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in mice. PLoS One, 7, e42422.
28. Darnell, J.C., Van Driesche, S.J., Zhang, C., Hung, K.Y., Mele, A., Fraser, C.E., Stone, E.F., Chen, C., Fak, J.J., Chi, S.W. et al. (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell, 146, 247-261.
29. Hoeffer, C.A., Sanchez, E., Hagerman, R.J., Mu, Y., Nguyen, D.V., Wong, H., Whelan, A.M., Zukin, R.S., Klann, E. and Tassone, F. (2012) Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes. Brain Behav., 11, 332-341.
30. Kumar, V., Kim, K., Joseph, C., Kourrich, S., Yoo, S.H., Huang, H.C., Vitaterna, M.H., de Villena, F.P., Churchill, G., Bonci, A. et al. (2013) C57BL/6Nmutation in Cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science, 342, 1508-1512.
31. Spencer, C.M., Alekseyenko, O., Hamilton, S.M., Thomas, A.M., Serysheva, E., Yuva-Paylor, L.A. and Paylor, R. (2011) Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Autism Res., 4, 40-56.
32. Sidorov, M.S., Auerbach, B.D. and Bear, M.F. (2013) Fragile X mental retardation protein and synaptic plasticity. Mol. Brain, 6, 15.
33. Soderling,S.H., Guire, E.S.,Kaech,S.,White, J.,Zhang,F., Schutz, K., Langeberg, L.K., Banker, G., Raber, J. and Scott, J.D. (2007) A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory. J. Neurosci., 27, 355-365.
34. Bhattacharya, A., Kaphzan, H., Alvarez-Dieppa, A.C., Murphy, J.P., Pierre, P. and Klann, E. (2012) Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron, 76, 325-337.
35. Portera-Cailliau, C. (2012) Which comes first in fragile X syndrome, dendritic spine dysgenesis or defects in circuit plasticity? Neuroscientist, 18, 28-44.
36. Cruz-Martin, A., Crespo, M. and Portera-Cailliau, C. (2012) Glutamate induces the elongation of early dendritic protrusions via mGluRs in wild type mice, but not in fragile X mice. PLoS One, 7, e32446.
37. Vanderklish, P.W. and Edelman, G.M. (2002) Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons. Proc. Natl Acad. Sci. USA, 99, 1639-1644.
38. Bassell, G.J. and Warren, S.T. (2008) Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron, 60, 201-214.
39. Todd, P.K., Mack, K.J. and Malter, J.S. (2003) The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc. Natl Acad. Sci. USA, 100, 14374-14378.
40. Westmark, C.J. and Malter, J.S. (2007) FMRP mediates mGluR5- dependent translation of amyloid precursor protein. PLoS Biol., 5, e52.
41. Kim, Y., Sung, J.Y., Ceglia, I., Lee, K.W., Ahn, J.H., Halford, J.M., Kim, A.M., Kwak, S.P., Park, J.B., Ho Ryu, S. et al. (2006) Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology. Nature, 442, 814-817.
42. Padrick, S.B., Cheng, H.C., Ismail, A.M., Panchal, S.C., Doolittle, L.K., Kim, S., Skehan, B.M., Umetani, J., Brautigam, C.A., Leong, J.M. et al. (2008) Hierarchical regulation of WASP/WAVE proteins. Mol. Cell, 32, 426-438.
43. Cajigas, I.J., Tushev, G.,Will, T.J., tom Dieck, S., Fuerst, N. and Schuman, E.M. (2012) The local transcriptome in the synaptic neuropil revealed by deep sequencing and high-resolution imaging. Neuron, 74, 453-466.
44. Han, K., Kim, M.H., Seeburg, D., Seo, J., Verpelli, C., Han, S., Chung, H.S., Ko, J., Lee, H.W., Kim, K. et al. (2009) Regulated RalBP1 binding to RalA and PSD-95 controls AMPA receptor endocytosis and LTD. PLoS Biol., 7, e1000187.
45. Koressaar, T. and Remm, M. (2007) Enhancements and modifications of primer design program Primer3. Bioinformatics, 23, 1289-1291.
46. Han, K., Gennarino, V.A., Lee, Y., Pang, K., Hashimoto-Torii, K., Choufani, S., Raju, C.S., Oldham, M.C., Weksberg, R., Rakic, P. et al. (2013) Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p. Genes Dev., 27, 485-490.
47. Han, K., Holder, J.L. Jr., Schaaf, C.P., Lu, H., Chen, H., Kang, H., Tang, J.,Wu, Z., Hao, S., Cheung, S.W. et al. (2013) SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature, 503, 72-77.